Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib Maintenance in Gastric Cancer
NCT02509806Phase 3Unknown
- Sponsor
- Hebei Medical University
- Start
- Jul 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Rivoceranib in gastric cancer (GC), sponsored by Hebei Medical University. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02509806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509806.